Skip to content

To evaluate the benefit of cardiac resynchronization therapy pacemaker in patients with right ventricular apical pacing induced ventricular dyssynchrony.

Efficacy of the PreseNce of Right Ventricular Apical Pacing Induced Ventricular DyssyncHrony as a Guiding PArameter for BiveNtricular PaCing in PatiEnts with Bradycardia and Normal Ejection Fraction - ENHANCE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/03/002526
Enrollment
177
Registered
2012-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Heart block and left ventricular ejection fraction more than 45%

Interventions

Intervention1: CRT- Pacemaker: A St. Jude Medical cardiac resynchronization therapy pacemaker (CRT-P) Frontier II 5596 or a more recent CE marked CRT-P with similar capabilities. Control Intervention1

Sponsors

SJM International Inc
Lead Sponsor
St Jude Medical India Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patient meets current indications for implantation of a DDDR pacemaker Patient is geographically stable and willing to comply with the required follow-up schedule Patient has LVEF greater than 45% Patient has atrioventricular block (IIo or above) Patient has adequate echocardiographic images to measure LV volumes and LV ejection fraction

Exclusion criteria

Exclusion criteria: Patient has permanent atrial fibrillation (AF) Patient has unstable angina or an acute coronary syndrome Patient has undergone percutaneous coronary intervention or coronary artery bypass surgery within the previous 3 months Patient life expectancy is less than 1 year Patient is less than 18 years old Patient is pregnant Patient has received a heart transplant

Design outcomes

Primary

MeasureTime frame
LVEF for assessment of LV systolic function LV end-systolic volume LVESV) for assessment of LV remodelingTimepoint: Month 12

Secondary

MeasureTime frame
NYHA Class Assessment; Left Ventricular End Diastolic Volume & 6 Minute Hall Walk testTimepoint: Month 12

Countries

Hong Kong, India, Italy, United Kingdom

Contacts

Public ContactSumit Anand

St. Jude Medical India Pvt. Ltd

sanand@sjm.com918860661364

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026